5 research outputs found
Monitoring Risk Factors and Improving Adherence to Therapy in Patients With Chronic Kidney Disease (Smit-CKD Project): Pilot Observational Study
Background: Chronic kidney disease is a major public health issue, with about 13% of the general adult population and 30%
of the elderly affected. Patients in the last stage of this disease have an almost uniquely high risk of death and cardiovascular
events, with reduced adherence to therapy representing an additional risk factor for cardiovascular morbidity and mortality.
Considering the increased penetration of mobile phones, a mobile app could educate patients to autonomously monitor cardiorenal
risk factors.
Objective: With this background in mind, we developed an integrated system of a server and app with the aim of improving
self-monitoring of cardiovascular and renal risk factors and adherence to therapy.
Methods: The software infrastructure for both the Smit-CKD server and Smit-CKD app was developed using standard
web-oriented development methodologies preferring open source tools when available. To make the Smit-CKD app suitable for
Android and iOS, platforms that allow the development of a multiplatform app starting from a single source code were used. The
integrated system was field tested with the help of 22 participants. User satisfaction and adherence to therapy were measured by
questionnaires specifically designed for this study; regular use of the app was measured using the daily reports available on the
platform.
Results: The Smit-CKD app allows the monitoring of cardiorenal risk factors, such as blood pressure, weight, and blood glucose.
Collected data are transmitted in real time to the referring general practitioner. In addition, special reminders improve adherence
to the medication regimen. Via the Smit-CKD server, general practitioners can monitor the clinical status of their patients and
their adherence to therapy. During the test phase, 73% (16/22) of subjects entered all the required data regularly and sent feedback
on drug intake. After 6 months of use, the percentage of regular intake of medications rose from 64% (14/22) to 82% (18/22).
Analysis of the evaluation questionnaires showed that both the app and server components were well accepted by the users.
Conclusions: Our study demonstrated that a simple mobile app, created to self-monitor modifiable cardiorenal risk factors and
adherence to therapy, is well tolerated by patients affected by chronic kidney disease. Further studies are required to clarify if
the use of this integrated system will have long-term effects on therapy adherence and if self-monitoring of risk factors will
improve clinical outcomes in this population
Fundamentals and Applications of the Receiver Operating Characteristic Curve Analysis in the Research of Endothelial Dysfunction in Chronic Kidney Disease
Endothelial dysfunction (ED) starts early in chronic kidney disease (CKD) and is the hallmark of atherosclerosis in these patients. During recent years, numerous markers have emerged, aiming to predict the onset of ED in CKD patients. Therefore, there is a need to evaluate and assess the discriminatory ability (or diagnostic accuracy) of such a marker (i.e., the ability to correctly classify individuals as having a given disease or not) and identify the optimal cut-off value. A receiver operating characteristic (ROC) curve analysis has been used in the majority of the research papers evaluating the predictive ability of a marker of ED. It is a graphical plot combining pairs of sensitivity (true positive rate) on the y axis and the complement of specificity (1—specificity, false positive rate) in the x axis, corresponding to several of the cut-off values covering the complete range of possible values that this test/marker might take. Herein, using a series of practical examples derived from clinical studies on ED in the special population of CKD, we address the principles, fundamentals, advantages and limitations regarding the interpretation of the ROC analysis
Home Pulse Pressure Predicts Death and Cardiovascular Events in Peritoneal Dialysis Patients
Increased arterial hypertension represents a prevalent condition in peritoneal dialysis patients that is often related to volume expansion. Pulse pressure is a robust predictor of mortality in dialysis patients, but its association with mortality is unknown in peritoneal patients. We investigated the relationship between home pulse pressure and survival in 140 PD patients. During a mean follow-up of 35 months, 62 patients died, and 66 experienced the combined event death/CV events. In a crude COX regression analysis, a five-unit increase in HPP was associated with a 17% increase in the hazard ratio of mortality (HR: 1.17, 95% CI 1.08–1.26 p p = 0.001). Similar results were obtained considering the combined event death–CV events as an outcome. Home pulse pressure represents, in part, arterial stiffness, and it is strongly related to all-cause mortality in peritoneal patients. In these high cardiovascular risk populations, it is important to maintain optimal blood pressure control, but it is fundamental to consider all the other cardiovascular risk indicators, such as pulse pressure. Home pulse pressure measurement is easy and feasible and can add important information for the identification and management of high-risk patients
In Vitro Activity of Sulbactam-Durlobactam against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: A Multicentre Report from Italy
In the present study, the in vitro activity of the sulbactam-durlobactam (SUL-DUR) combination was evaluated against 141 carbapenem-resistant A. baumannii (CRAb) clinical strains collected from six Italian laboratories. Over half (54.6%) of these isolates were resistant to colistin. The SUL-DUR combination was active against these CRAb isolates with MIC50 and MIC90 values of 0.5 mg/L and 4 mg/L, respectively. Only eleven isolates were resistant to SUL-DUR with MIC values ranging from 8 to 128 mg/L. The SUL-DUR resistant A. baumannii exhibited several antimicrobial resistance genes (ARGs) such as blaOXA-20, blaOXA-58, blaOXA-66, blaADC-25, aac(6')-Ib3 and aac(6')-Ib-cr and mutations in gyrA (S81L) and parC (V104I, D105E). However, in these isolates, mutations Q488K and Y528H were found in PBP3. Different determinants were also identified in these CRAb isolates, including adeABC, adeFGH, adeIJK, abeS, abaQ and abaR, which encode multidrug efflux pumps associated with resistance to multiple antibacterial agents. This is the first report on the antimicrobial activity of SUL-DUR against carbapenem-resistant A. baumannii isolates selected from multiple regions in Italy